218 related articles for article (PubMed ID: 10976782)
1. Endothelin and pulmonary hypertension.
Chen YF; Oparil S
J Cardiovasc Pharmacol; 2000; 35(4 Suppl 2):S49-53. PubMed ID: 10976782
[TBL] [Abstract][Full Text] [Related]
2. The orally active nonpeptide endothelin A-receptor antagonist A-127722 prevents and reverses hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in Sprague-Dawley rats.
Chen SJ; Chen YF; Opgenorth TJ; Wessale JL; Meng QC; Durand J; DiCarlo VS; Oparil S
J Cardiovasc Pharmacol; 1997 Jun; 29(6):713-25. PubMed ID: 9234651
[TBL] [Abstract][Full Text] [Related]
3. Endothelin in the pulmonary circulation with special reference to hypoxic pulmonary vasoconstriction.
Holm P
Scand Cardiovasc J Suppl; 1997; 46():1-40. PubMed ID: 9265559
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Tilton RG; Munsch CL; Sherwood SJ; Chen SJ; Chen YF; Wu C; Block N; Dixon RA; Brock TA
Pulm Pharmacol Ther; 2000; 13(2):87-97. PubMed ID: 10799286
[TBL] [Abstract][Full Text] [Related]
5. Effect of SB 217242 on hypoxia-induced cardiopulmonary changes in the high altitude-sensitive rat.
Underwood DC; Bochnowicz S; Osborn RR; Luttmann MA; Louden CS; Hart TK; Elliott JD; Hay DW
Pulm Pharmacol Ther; 1999; 12(1):13-26. PubMed ID: 10208832
[TBL] [Abstract][Full Text] [Related]
6. Endothelin B receptor deficiency potentiates ET-1 and hypoxic pulmonary vasoconstriction.
Ivy D; McMurtry IF; Yanagisawa M; Gariepy CE; Le Cras TD; Gebb SA; Morris KG; Wiseman RC; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2001 May; 280(5):L1040-8. PubMed ID: 11290529
[TBL] [Abstract][Full Text] [Related]
7. Endothelin receptor changes in hypoxia-induced pulmonary hypertension in the newborn piglet.
Gosselin R; Gutkowska J; Baribeau J; Perreault T
Am J Physiol; 1997 Jul; 273(1 Pt 1):L72-9. PubMed ID: 9252542
[TBL] [Abstract][Full Text] [Related]
8. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat.
McCulloch KM; Docherty C; MacLean MR
Br J Pharmacol; 1998 Apr; 123(8):1621-30. PubMed ID: 9605569
[TBL] [Abstract][Full Text] [Related]
9. Role of endothelin-1 in exposure to high altitude: Acute Mountain Sickness and Endothelin-1 (ACME-1) study.
Modesti PA; Vanni S; Morabito M; Modesti A; Marchetta M; Gamberi T; Sofi F; Savia G; Mancia G; Gensini GF; Parati G
Circulation; 2006 Sep; 114(13):1410-6. PubMed ID: 16982943
[TBL] [Abstract][Full Text] [Related]
10. Emergence of smooth muscle cell endothelin B-mediated vasoconstriction in lambs with experimental congenital heart disease and increased pulmonary blood flow.
Black SM; Mata-Greenwood E; Dettman RW; Ovadia B; Fitzgerald RK; Reinhartz O; Thelitz S; Steinhorn RH; Gerrets R; Hendricks-Munoz K; Ross GA; Bekker JM; Johengen MJ; Fineman JR
Circulation; 2003 Sep; 108(13):1646-54. PubMed ID: 12963646
[TBL] [Abstract][Full Text] [Related]
11. TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets.
Perreault T; Berkenbosch JW; Barrington KJ; Decker ER; Wu C; Brock TA; Baribeau J
Pediatr Res; 2001 Sep; 50(3):374-83. PubMed ID: 11518825
[TBL] [Abstract][Full Text] [Related]
12. The role of atrial natriuretic peptide and endothelin in hypoxia induced pulmonary hypertension.
Chen YF; Li H; Elton TS; Yang RH; Jin H; Oparil S
Chin J Physiol; 1994; 37(3):165-83. PubMed ID: 7705179
[TBL] [Abstract][Full Text] [Related]
13. Nonpeptide endothelin receptor antagonists. VIII: attentuation of acute hypoxia-induced pulmonary hypertension in the dog.
Willette RN; Ohlstein EH; Mitchell MP; Sauermelch CF; Beck GR; Luttmann MA; Hay DW
J Pharmacol Exp Ther; 1997 Feb; 280(2):695-701. PubMed ID: 9023281
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 mediates nitro-L-arginine vasoconstriction of hypertensive rat lungs.
Muramatsu M; Rodman DM; Oka M; McMurtry IF
Am J Physiol; 1997 May; 272(5 Pt 1):L807-12. PubMed ID: 9176242
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-1 and the pulmonary vascular response to altitude: a new therapeutic target?
Rubin LJ
Circulation; 2006 Sep; 114(13):1350-1. PubMed ID: 17000920
[No Abstract] [Full Text] [Related]
16. Increased endothelin receptor gene expression in hypoxic rat lung.
Li H; Elton TS; Chen YF; Oparil S
Am J Physiol; 1994 May; 266(5 Pt 1):L553-60. PubMed ID: 8203548
[TBL] [Abstract][Full Text] [Related]
17. Absence of cyclooxygenase-2 exacerbates hypoxia-induced pulmonary hypertension and enhances contractility of vascular smooth muscle cells.
Fredenburgh LE; Liang OD; Macias AA; Polte TR; Liu X; Riascos DF; Chung SW; Schissel SL; Ingber DE; Mitsialis SA; Kourembanas S; Perrella MA
Circulation; 2008 Apr; 117(16):2114-22. PubMed ID: 18391113
[TBL] [Abstract][Full Text] [Related]
18. Effects of ET-A receptor blockade on eNOS gene expression in chronic hypoxic rat lungs.
Blumberg FC; Wolf K; Arzt M; Lorenz C; Riegger GA; Pfeifer M
J Appl Physiol (1985); 2003 Feb; 94(2):446-52. PubMed ID: 12391096
[TBL] [Abstract][Full Text] [Related]
19. [The role of endothelin-B receptors in hypoxic pulmonary hypertension].
Hayashi A; Tatsumi K; Sugito K; Igari H; Kasahara Y; Kimura H; Kuriyama T
Nihon Kokyuki Gakkai Zasshi; 2000 Feb; 38(2):85-91. PubMed ID: 10774165
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of 3-azabicyclo[3,2,1] octane-1-yl-l-leucyl-d-tryptophanyl-d-4-Cl-phenylalanine: A novel ET(A) receptor-selective antagonist.
Li X; Liu KL; Zheng JQ; Chi MG; Dong JJ; Dong SJ; Gong ZH
Pulm Pharmacol Ther; 2008 Oct; 21(5):780-7. PubMed ID: 18602014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
